Metastatic Esophageal Squamous Cell Carcinoma
Also known as: Metastatic Oesophageal squamous cell carcinoma / Esophageal Squamous Cell Carcinoma Metastatic / Oesophageal squamous cell carcinoma metastatic / Esophageal squamous cell carcinoma site unspecified stage IV / Oesophageal squamous cell carcinoma site unspecified stage IV / Oesophageal squamous cell carcinoma stage IV / Esophageal squamous cell carcinoma stage IV
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06186 | Ipilimumab | A human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma. |
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
| DB14922 | Tislelizumab | An IgG4 variant monoclonal antibody against PD-1 indicated for the treatment of unresectable, locally advanced or metastatic esophageal squamous cell carcinoma |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11740 | Adavosertib | 1 | Active Not Recruiting | 1 |
| DB11945 | Avelumab | 2 | Unknown Status | 1 |
| DB16680 | Cadonilimab | 2 | Not Yet Recruiting | 1 |
| DB01101 | Capecitabine | 2 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Not Yet Recruiting | 1 |
| DB12250 | Cixutumumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Not Yet Recruiting | 1 |
| DB12257 | Platinum | 2 / 3 | Recruiting | 1 |
| DB15765 | Sintilimab | 2 / 3 | Recruiting | 1 |
| DB00515 | Cisplatin | 3 | Recruiting | 1 |
| DB00544 | Fluorouracil | 3 | Recruiting | 1 |
| DB09078 | Lenvatinib | 3 | Recruiting | 1 |
| DB00650 | Leucovorin | 3 | Recruiting | 1 |
| DB11596 | Levoleucovorin | 3 | Recruiting | 1 |
| DB00526 | Oxaliplatin | 3 | Recruiting | 1 |
| DB01229 | Paclitaxel | 3 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 3 | Recruiting | 1 |